Base Wealth Management
MDCX icon

Base Wealth Management’s Medicus Pharma MDCX Stock Holding History

Base Wealth Management’s Portfolio MDCX Stock Details MDCX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-231
Closed -$26.7K – 66
2025
Q3 		$26.7K Hold
231
– – 0.02% 63
2025
Q2 		$34.5K Hold
231
– – 0.02% 55
2025
Q1 		$42.9K Buy
+231
New +$36.3K 0.03% 52

Other funds holding MDCX

Armistice Capital
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Interchange Capital Partners
Interchange Capital Partners Pittsburgh, Pennsylvania $598M AUM 31.79% 1-Year Est. Return
Private Advisor Group
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Wilmington Savings Fund Society
Wilmington Savings Fund Society Wilmington, Delaware $4.39B AUM 17.99% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
May Hill Capital
May Hill Capital Cohasset, Massachusetts $510M AUM 23.75% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $77B AUM 19.24% 1-Year Est. Return
HRT Financial
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Base Wealth Management's MDCX Position: Q4 2025 in Review

Base Wealth Management sold out of Medicus Pharma (MDCX) in Q4 2025, closing a stake of 231 shares — an estimated $26.7K sold.

Base Wealth Management first reported a position in MDCX in Q1 2025 and held it in 3 quarters. The position peaked at $42.9K in Q1 2025. 21 funds tracked by Wall St. Rank hold MDCX as of Q4 2025.

  • Base Wealth Management reported no remaining Medicus Pharma position as of Q4 2025 after selling out during the quarter.
  • Base Wealth Management sold 231 Medicus Pharma shares in Q4 2025, an estimated $26.7K.
  • Base Wealth Management first reported a position in Medicus Pharma in Q1 2025 and held it in 3 quarters.
  • Base Wealth Management's Medicus Pharma position peaked at $42.9K in Q1 2025.
  • 21 funds tracked by Wall St. Rank held Medicus Pharma as of Q4 2025.

Based on Base Wealth Management's 13F filing for Q4 2025, filed 21 Jan 2026.